Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial.
Document Type
Journal Article
Publication Date
10-17-2016
Journal
Lancet HIV
DOI
10.1016/S2352-3018(16)30121-7
APA Citation
Gaur, A., Kizito, H., Prasitsueubsai, W., Rakhmanina, N., Rassool, M., Chakraborty, R., Batra, J., Kosalaraksa, P., Luesomboon, W., Porter, D., Shao, Y., Myers, M., Ting, L., SenGupta, D., Quirk, E., & Rhee, M. (2016). Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial.. Lancet HIV, (). http://dx.doi.org/10.1016/S2352-3018(16)30121-7
Peer Reviewed
1